Literature DB >> 1655116

Tumor invasion and extracellular matrix degradative enzymes: regulation of activity by organ factors.

M Nakajima1, A M Chop.   

Abstract

Degradation of the extracellular matrix (ECM) during cellular invasion is important to the formation of tumor metastasis. Several types of ECM degradative enzymes have been implicated in metastatic invasion by malignant cells. These enzymes are regulated by various factors which vary qualitatively and quantitatively between organs. Tissue and plasma activators of zymogens, enzyme inhibitors, and cell surface enzyme receptors directly control localized enzyme activities, and the expression of enzymes is modulated by various cytokines, growth factors and ECM components. Thus, the interaction of tumor cells with an organ environment affects the metastatic behavior of the cells. This organ factor regulation is illustrated using human colon carcinoma cells implanted in different organ sites of nude mice. The cells growing in the cecal wall produced high levels of ECM degradative enzymes and metastasized to lymph nodes and liver. In contrast, enzyme production was repressed in colon carcinoma tumors growing in the subcutis and no metastases were formed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655116

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  37 in total

1.  Increased matrix metalloproteinase-9 activity in human ovarian cancer cells cultured with conditioned medium from human peritoneal tissue.

Authors:  K Shibata; F Kikkawa; A Nawa; K Tamakoshi; N Suganuma; Y Tomoda
Journal:  Clin Exp Metastasis       Date:  1997-11       Impact factor: 5.150

2.  Enhanced prolidase activity and decreased collagen content in breast cancer tissue.

Authors:  Marzanna Cechowska-Pasko; Jerzy Pałka; Marek Z Wojtukiewicz
Journal:  Int J Exp Pathol       Date:  2006-08       Impact factor: 1.925

3.  Major co-localization of the extracellular-matrix degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils.

Authors:  F Mollinedo; M Nakajima; A Llorens; E Barbosa; S Callejo; C Gajate; A Fabra
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

4.  Collagen metabolism disturbances are accompanied by an increase in prolidase activity in lung carcinoma planoepitheliale.

Authors:  E Karna; A Surazynski; J Palka
Journal:  Int J Exp Pathol       Date:  2000-10       Impact factor: 1.925

5.  Degradation of endothelial cell matrix collagen is correlated with induction of stromelysin by an activated ras oncogene.

Authors:  J E LoSardo; B S Goggin; O Bohoslawec; A Neri
Journal:  Clin Exp Metastasis       Date:  1995-07       Impact factor: 5.150

6.  Role of hepatocyte growth factor/c-Met signaling in regulating urokinase plasminogen activator on invasiveness in human hepatocellular carcinoma: a potential therapeutic target.

Authors:  Kyung Hee Lee; Eun Young Choi; Myung Soo Hyun; Byung Ik Jang; Tae Nyeun Kim; Heon Ju Lee; Jong Yuel Eun; Hong Gin Kim; Sung Soo Yoon; Dong Sik Lee; Jung Hye Kim; Jae-Ryong Kim
Journal:  Clin Exp Metastasis       Date:  2007-11-09       Impact factor: 5.150

7.  Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13.

Authors:  H Fujii; M Nakajima; I Saiki; J Yoneda; I Azuma; T Tsuruo
Journal:  Clin Exp Metastasis       Date:  1995-09       Impact factor: 5.150

8.  Urokinase type plasminogen activator receptor expression in colorectal neoplasms.

Authors:  S Suzuki; Y Hayashi; Y Wang; T Nakamura; Y Morita; K Kawasaki; K Ohta; N Aoyama; S R Kim; H Itoh; Y Kuroda; W F Doe
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

Review 9.  Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis.

Authors:  I J Fidler
Journal:  Cancer Metastasis Rev       Date:  1991-10       Impact factor: 9.264

Review 10.  Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review.

Authors:  P Basset; C Wolf; P Chambon
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.